A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic function

Publikation

A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic function

Wissenschaftlicher Artikel/Review - 25.09.2014

Slingerland Marije, Valera Sue-Zette, Waldron Edward, Mu Song, Porro Maria G, Loman Niklas, Sandstrom Per, Sharma Sunil, Clive Sally, Hess Dagmar, Gelderblom Hans

Slingerland, Marije

Hess, Dagmar

Oberärztin mbF
Medizinische Onkologie und Hämatologie · Dept. I

Clive, Sally

A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic function

Slingerland, Marije

Hess, Dagmar

Clive, Sally

Sharma, Sunil

Sandstrom, Per

Loman, Niklas

Porro, Maria G

Mu, Song

Waldron, Edward

Valera, Sue-Zette

Gelderblom, Hans